HIPRA

Firma Premium

241 Followers 9 Veröffentlichungen 3 Folgen

HIPRA is a biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service.

A company that works with the latest technological advances to create innovative solutions that improve world health.

R&D projects are the basis of the knowledge. HIPRA has more than 50 years of experience dedicated to the research and development of different vaccines. With a unique organizational model, HIPRA controls all the processes of the value chain, generating singular know-how and becoming a reference in the research, production, and commercialization of biologics.

HIPRA has a solid international presence, commercial subsidiaries and a global distribution network, allowing products to reach costumers from more than 100 countries, covering the 5 continents.

Aktinobacillose/porzine Pleuropneumonie Aujeszky-Krankheit Autogene Impfstoffe Circovirus/PCV Clostridiose Colibacillose Glaesserella parasuis/Glässersche Krankheit Influenza/Grippe Erysipel Mykoplasmen/enzootische Pneumonie Parvovirus PRRS Atrophische Rhinitis Software

Nachricht senden

https://www.hipra.com

hipra@hipra.com

+34 972430660

Av. La Selva, 135
17170 GIRONA
Spanien

HIPRA

241 Followers 9 Veröffentlichungen 3 Folgen

Beschäftigung Produkte 17 Veranstaltung 1 Veröffentlichungen 9 Gesponserte Artikel auf 333 75

HIPRAFirma - Spanien18-Nov-2024

𝗖𝗮𝗽𝘀𝘂𝗹𝗲 𝟭: Luís Sanjoaquín (Thinkinpig) explains the importance of 𝗻𝗲𝗼𝗻𝗮𝘁𝗮𝗹 𝗱𝗶𝗮𝗿𝗿𝗵𝗲𝗮 in piglets.

Gefällt mirkommentieren

teilenMeine Favoriten

HIPRAFirma - Spanien13-Nov-2023

New webinar on 16th November!
"Zinc Oxide Transition: Forging resilient swine production with advanced approaches to vaccination and nutrition"
Register now here: https://event.meetmaps.com/webinarzincoxide/en/info

Webinar Zinc Oxide

Gefällt mirkommentieren

teilenMeine Favoriten

HIPRAFirma - Spanien28-Okt-2020

Mhyosphere® PCV ID: History starts here

On the 8th of October, HIPRA presents to the European countries its new vaccine Mhyosphere® PCV ID, the first needle-free intradermal vaccine for protection against M.hyo and PCV2.

Gefällt mirkommentieren

teilenMeine Favoriten

HIPRAFirma - Spanien13-Jul-2018